We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
Cap. Flow
-$2.79B
Cap. Flow %
-20.16%
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$66.4M
2
VLO icon
Valero Energy
VLO
+$28.9M
3
SLB icon
SLB Ltd
SLB
+$24.8M
4
BNY
Bank of New York Mellon
BNY
+$22.6M
5
PEP icon
PepsiCo
PEP
+$20.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$182M
2
AAPL icon
Apple
AAPL
+$148M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.9M
4
AMGN icon
Amgen
AMGN
+$72.1M
5
TSLA icon
Tesla
TSLA
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Technology 28.78%
3 Financials 8.15%
4 Consumer Discretionary 7.54%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GNRC icon
751
Generac Holdings
GNRC
$11.6B
– –
-3,569
Closed -$355K
GNW icon
752
Genworth Financial
GNW
$3.79B
– –
-500,287
Closed -$2.31M
GOOD
753
Gladstone Commercial Corp
GOOD
$627M
– –
-10,000
Closed -$116K
GTN icon
754
Gray Television
GTN
$409M
– –
-47,595
Closed -$382K
HAE icon
755
Haemonetics
HAE
$3.63B
– –
-6,123
Closed -$466K
HR icon
756
Healthcare Realty
HR
$7.46B
– –
-21,438
Closed -$381K
HRB icon
757
H&R Block
HRB
$5.37B
– –
-258,483
Closed -$8.39M
HSIC icon
758
Henry Schein
HSIC
$9.64B
– –
-15,023
Closed -$1.13M
HURN icon
759
Huron Consulting
HURN
$1.89B
– –
-68,747
Closed -$5.09M
PPLI
760
People Inc
PPLI
$3.15B
– –
-11,184
Closed -$436K
INO icon
761
Inovio Pharmaceuticals
INO
$79.4M
– –
-31,668
Closed -$287K
IP icon
762
International Paper
IP
$22.5B
– –
-8,489
Closed -$282K
JKHY icon
763
Jack Henry & Associates
JKHY
$10.9B
– –
-7,375
Closed -$1.02M
JNPR
764
DELISTED
Juniper Networks
JNPR
– –
-18,282
Closed -$579K
OPLN
765
Openlane
OPLN
$4.25B
– –
-396,111
Closed -$4.99M
KELYA icon
766
Kelly Services Class A
KELYA
$545M
– –
-327,090
Closed -$4.99M
LBRDK icon
767
Liberty Broadband Class C
LBRDK
$4.44B
– –
-12,615
Closed -$949K
LEA icon
768
Lear
LEA
$7.26B
– –
-4,745
Closed -$609K
LII icon
769
Lennox International
LII
$19B
– –
-2,357
Closed -$545K
LSCC icon
770
Lattice Semiconductor
LSCC
$16.8B
– –
-19,284
Closed -$1.7M
MAN icon
771
ManpowerGroup
MAN
$2.5B
– –
-64,631
Closed -$4.91M
MASI
772
DELISTED
Masimo
MASI
– –
-2,813
Closed -$478K
MHK icon
773
Mohawk Industries
MHK
$7.05B
– –
-3,713
Closed -$343K
MMSI icon
774
Merit Medical Systems
MMSI
$4.54B
– –
-6,798
Closed -$463K
MODV
775
DELISTED
ModivCare
MODV
– –
-5,571
Closed -$431K
29 30
31
32 33

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2023 Portfolio in Review

As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.

  • Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
  • Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
  • Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
  • Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
  • Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
  • Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.